You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Innovation-TiFP4-C101

Showing 1 - 25 of 8,457
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Functional Disability Trial in Odense C (PONDUS®)

Not yet recruiting
  • Functional Disability
  • PONDUS®
  • Odense C, Denmark
    University of Southern Denmark
Sep 5, 2023

Cancer, Covid-19 Trial in Canada (IMM-101, Observation)

Active, not recruiting
  • Cancer
  • Covid-19
  • IMM-101
  • Observation
  • Hamilton, Ontario, Canada
  • +7 more
Jun 23, 2022

Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection, C. Diff Trial in Canada, United States (CP101)

Completed
Has Results
  • Clostridium Difficile Infection
  • +10 more
  • CP101
  • Scottsdale, Arizona
  • +56 more
Aug 10, 2022

Obesity or Overweight Trial in Japan, Taiwan (Cagrilintide, Semaglutide, Placebo Semaglutide)

Not yet recruiting
  • Obesity or Overweight
  • Koriyama-shi, Fukushima, Japan, Japan
  • +21 more
Apr 3, 2023

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Rehabilitation, Orthopedic Disorder Trial in Sherbrooke (Phone call follow-up, Telerehabilitation follow-up)

Completed
  • Rehabilitation
  • Orthopedic Disorder
  • Phone call follow-up
  • Telerehabilitation follow-up
  • Sherbrooke, Quebec, Canada
  • +1 more
Sep 27, 2021

Prader-Willi Syndrome Trial in Australia, Canada, United States (3.2 mg intranasal carbetocin, 9.6 mg intranasal carbetocin, )

Completed
Has Results
  • Prader-Willi Syndrome
  • 3.2 mg intranasal carbetocin
  • +2 more
  • Birmingham, Alabama
  • +23 more
Jul 18, 2022

Clostridium Difficile Infection Recurrence Trial in Canada, United States (Full Spectrum Microbiota, Placebo)

Completed
Has Results
  • Clostridium Difficile Infection Recurrence
  • Full Spectrum Microbiota
  • Placebo
  • Scottsdale, Arizona
  • +57 more
Jun 10, 2022

Adenoid Cystic Carcinoma Trial in Worldwide (AL101)

Active, not recruiting
  • Adenoid Cystic Carcinoma
  • Los Angeles, California
  • +16 more
Dec 10, 2021

Familial Chylomicronemia Syndrome Trial in Canada, Sweden, United States (Olezarsen)

Recruiting
  • Familial Chylomicronemia Syndrome
  • Huntington Beach, California
  • +10 more
Aug 4, 2022

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • San Francisco, California
  • +35 more
May 25, 2022

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • New Orleans, Louisiana
  • +5 more
Dec 13, 2022

Acne Vulgaris Trial in Canada, United States (Imsidolimab, Placebo)

Completed
  • Acne Vulgaris
  • Hot Springs, Arkansas
  • +14 more
Sep 19, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Recurrent DLBCL, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Houston (drug, procedure, other, biological)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Acne Vulgaris Trial in Canada, United States (IDP-126 Gel, IDP-126 Vehicle Gel)

Completed
  • Acne Vulgaris
  • IDP-126 Gel
  • IDP-126 Vehicle Gel
  • Bryant, Arkansas
  • +12 more
Jan 18, 2022

Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • San Diego, California
  • +99 more
Oct 6, 2023

Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

Terminated
Has Results
  • Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent

Recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +6 more
  • Ascorbic Acid
  • +12 more
  • Scottsdale, Arizona
  • +4 more
May 26, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

Recruiting
  • Thyroid
  • +18 more
  • New Haven, Connecticut
  • +6 more
Apr 8, 2022

Mantle Cell Lymphoma Trial in Houston (Bortezomib, Cyclophosphamide, Cytarabine)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic

Terminated
Has Results
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022